U.S. flag

An official website of the United States government

Display Settings:

Format
Sort by

Send to:

Choose Destination

Results in this book: 5

Clinical Review Report: Insulin degludec and liraglutide injection (Xultophy): (Novo Nordisk Canada Inc.): Indication: An adjunct to lifestyle modifications, for the once-daily treatment of adults with type 2 diabetes mellitus to improve glycemic control in combination with metformin, with or without sulfonylurea, when these combined with basal insulin (less than 50 U daily) or liraglutide (less than or equal to 1.8 mg daily) do not provide adequate glycemic control [Internet].

Clinical Review Report: Insulin degludec and liraglutide injection (Xultophy): (Novo Nordisk Canada Inc.): Indication: An adjunct to lifestyle modifications, for the once-daily treatment of adults with type 2 diabetes mellitus to improve glycemic control in combination with metformin, with or without sulfonylurea, when these combined with basal insulin (less than 50 U daily) or liraglutide (less than or equal to 1.8 mg daily) do not provide adequate glycemic control [Internet].

Ottawa (ON): Canadian Agency for Drugs and Technologies in Health; 2019 Dec.

Table of contents


1.
3.
5.

Display Settings:

Format
Sort by

Send to:

Choose Destination

Supplemental Content

Find related data

Search details

See more...

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...